Dr. Yanyan Lou is a medical oncologist and researcher with a special focus on lung cancer and the development of CAR-T cell therapies for the treatment of thoracic cancers. She treats patients with both lung cancer and mesothelioma at the Mayo Clinic in Jacksonville, Florida. Education and Career Dr. Lou earned her medical degree at
Dr. Rami Manochakian is a board-certified medical oncologist who specializes in thoracic malignancies. Lung cancer and pleural mesothelioma patients seeking care at the Mayo Clinic in Florida benefit from his experience, knowledge, and extensive research on thoracic malignancies of all types. Education and Career Dr. Manochakian earned his medical degree at the Aleppo University School
Dr. Aaron S. Mansfield is a medical oncologist and researcher at the Mayo Clinic in Rochester, Minnesota. As co-director of the Precision Cancer Therapeutics Program within the Mayo Clinic Center for Individualized Medicine, he has played a significant role in the development of new treatments for lung cancer and other thoracic malignancies, including the combination
Dr. Mohamed Shanshal is a hematologist and medical oncologist at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee. He specializes in treating patients with thoracic malignancies, including pleural mesothelioma and lung cancer. He is also a researcher developing targeted therapies, bio-specific T-cell engagers, and nano-oncology treatments to improve outcomes for patients with hard-to-treat cancers. Education and
Dr. Mathew Thomas is a cardiothoracic surgeon and the Director of Thoracic Surgery and Chair of Robotic Surgery at the Mayo Clinic in Jacksonville, Florida. His primary interest lies in improving and advancing the use of minimally invasive surgical techniques for the treatment of chest malignancies, including lung cancer and malignant pleural mesothelioma. Education and
Dr. Dennis Wigle is a thoracic surgeon and researcher at the Mayo Clinic in Rochester, Minnesota. As Chief of the Division of Thoracic Surgery, his focus is on understanding and treating lung cancer, esophageal cancer, and other thoracic malignancies, including pleural mesothelioma. Education and Career Dr. Wigle is certified in General Surgery and Thoracic Surgery by
For asbestos-exposed individuals, the specter of mesothelioma is always lurking in the background. Every cough or discomfort raises alarm bells that it could be the first sign of a deadly diagnosis. Researchers have been exploring the utility of a screening breath test to help allay these fears and provide an early detection tool. They reported on their
Dr. Giuseppe Giaccone is a hematologist and oncologist at Weill Cornell Medicine, seeing patients at NewYork-Presbyterian Hospital. He ranks among the world’s most highly respected practitioners in the treatment and study of lung cancer and in developmental therapeutics. In addition to his groundbreaking work in early clinical research, he is an expert in the biology
Back in 2009, the International Association for the Study of Lung Cancer presented a model they’d developed to help stage malignant mesothelioma cases. Since then, additional data has been added to the model’s database to continue enhancing its accuracy. This week, the group’s members attending its annual conference in Singapore learned that the model is
Dr. Stephen Liu is a hematologist and oncologist at MedStar Georgetown University Hospital. He focuses on thoracic malignancies, including lung cancer, thymic malignancies, and pleural mesothelioma. He has significant expertise in the development of novel therapeutic agents and in combining treatment protocols with the goal of improving patient outcomes. Education and Career Dr. Liu graduated